跳转至内容
Merck
CN

A111

Adenosine amine congener hydrate

solid, ≥98% (HPLC)

别名:

ADAC, N6-[4-[[[4-[[[(2-Aminoethyl)amino]carbonyl]methyl]-anilino]carbonyl]methyl]phenyl]adenosine hydrate

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C28H32N8O6 · xH2O
化学文摘社编号:
96760-69-9
分子量:
576.60 (anhydrous basis)
NACRES:
NA.77
PubChem Substance ID:
24890507
UNSPSC Code:
12352202
MDL number:
MFCD11045962
Assay:
≥98% (HPLC)
Form:
solid
Storage condition:
protect from light

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Adenosine amine congener hydrate, solid, ≥98% (HPLC)

InChI

1S/C28H32N8O6.H2O/c29-9-10-30-21(38)11-16-1-5-18(6-2-16)34-22(39)12-17-3-7-19(8-4-17)35-26-23-27(32-14-31-26)36(15-33-23)28-25(41)24(40)20(13-37)42-28;/h1-8,14-15,20,24-25,28,37,40-41H,9-13,29H2,(H,30,38)(H,34,39)(H,31,32,35);1H2/t20-,24-,25-,28-;/m1./s1

SMILES string

O.NCCNC(=O)Cc1ccc(NC(=O)Cc2ccc(Nc3ncnc4n(cnc34)[C@@H]5O[C@H](CO)[C@@H](O)[C@H]5O)cc2)cc1

InChI key

KPSYUNGHYKDIMQ-LWOJYUBXSA-N

assay

≥98% (HPLC)

form

solid

storage condition

protect from light

color

white

solubility

0.1 M acetic acid: 12 mM
DMSO: soluble

Gene Information

rat ... Adora1(29290)

Biochem/physiol Actions

Potent aqueous-soluble A1 adenosine receptor agonist.

Disclaimer

Photosensitive

Features and Benefits

This compound is featured on the Adenosine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
067K4712

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Karl Z Lukic et al.
Biomedical engineering online, 5, 54-54 (2006-10-20)
The objective was to determine the repeatability and stability of capnography interfaced with human exposure facility. Capnographic wave signals were obtained from five healthy volunteers exposed to particle-free, filtered air during two consecutive 5 min intervals, 10 min apart, within
Lindsea C Booth et al.
Clinical and experimental pharmacology & physiology, 35(11), 1316-1320 (2008-08-02)
1. Adenosine A(1) receptor activation is critical for endogenous neuroprotection from hypoxia-ischaemia, raising the possibility that treatment with A(1) receptor agonists may be an effective physiological protection strategy for vulnerable preterm infants. However, the A(1) receptor can mediate unwanted systemic
D K Von Lubitz et al.
European journal of pharmacology, 316(2-3), 171-179 (1996-12-05)
Although adenosine receptor-based treatment of cerebral ischemia and other neurodegenerative disorders has been frequently advocated, cardiovascular side effects and an uncertain therapeutic time window of such treatment have constituted major obstacles to clinical implementation. Therefore, we have investigated the neuroprotective
Tufi Dippe et al.
Arquivos brasileiros de cardiologia, 112(2), 121-128 (2018-12-21)
Obesity is associated with an increased risk of type 2 diabetes mellitus (DM), ischemic heart disease (IHD) and cardiovascular mortality. Several studies have demonstrated the diagnostic and prognostic value of single photon computed tomography-myocardial perfusion scintigraphy (SPECT-MPI) in the evaluation
D K Von Lubitz et al.
European journal of pharmacology, 302(1-3), 43-48 (1996-04-29)
Agonists of adenosine A1 receptors have been frequently proposed as candidates for clinical development in treatment of cerebral ischemia and stroke. Numerous experimental studies have shown that pre- and postischemic administration of these drugs results in a very significant reduction
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持